Last update 29 Jun 2024

Amtolmetin Guacil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amtolmetin, Amtolmetin guacil (INN), Amtolmetin-guacyl
+ [7]
Target
Mechanism
COX inhibitors(Cyclooxygenases inhibitors)
Active Indication
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
IT (01 Jul 1995),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC24H24N2O5
InChIKeyCWJNMKKMGIAGDK-UHFFFAOYSA-N
CAS Registry87344-06-7

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Inflammation
IT
01 Jul 1995
Pain---
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
mfhqmpdife(wsxuoispqd) = The development or worsening of arterial hypertension, as well as other cardiovascular complications, was not observed nvpjusfcei (acxgpgifry )
Positive
12 Jun 2019
Not Applicable
220
Amtolmetin guacil (AMG)
xbirrtqafe(qmshqbbqry) = There were no serious adverse events (AE). AE were graded as moderate and mild in 8 and 82% of cases, respectively. AE were recorded in 7.7% of the patients. sotlxvkeut (ishgpngkcl )
-
14 Jun 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free